Novartis: Obesity trials
The registry lists 16 Obesity studies with Novartis as lead sponsor. 0 are open to participants now and 12 have results posted.
Phase 1 1Phase 2 10Phase 4 5(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Study to Assess Safety, Tolerability and Efficacy of SC Administered MBL949 in Obese Participants With or Without T2DMTerminatedNCT05199090Phase 2Results posted
- Comparison of Secukinumab 300 mg Combined With a Lifestyle Intervention to Secukinumab Alone for the Treatment of Moderate to Severe Psoriasis Patients With Concomitant Metabolic SyndromeCompletedNCT03440736Phase 4Results posted
- A Dose-finding Study to Evaluate the Change in Weight After Treatment With LIK066 in Japanese Patients With ObesityCompletedNCT03320941Phase 2Results posted
- Effect of LIK066 on Reduction of Fatty Content in Livers of Obese PatientsCompletedNCT03205150Phase 2Results posted
- Effects of Carbohydrate in Diet and Supplements on the Gastrointestinal Tolerability of LIK066CompletedNCT03198767Phase 2Results posted
- Study of Pharmacodynamics of LIK066 in Overweight and Obese Women With Polycystic Ovary SyndromeCompletedNCT03152591Phase 2Results posted
- A Dose Finding Study to Assess the Effect of LIK066 Compared to Placebo or Empagliflozin in Patients With Type 2 Diabetes Mellitus and Heart FailureTerminatedNCT03152552Phase 2Results posted
- A Study to Evaluate the Change in Weight After 24 Weeks Treatment With LIK066 in Obese or Overweight AdultsCompletedNCT03100058Phase 2Results posted
- Safety, Pharmacokinetics and Efficacy of Bimagrumab in Overweight and Obese Patients With Type 2 DiabetesCompletedNCT03005288Phase 2Results posted
- Evaluation of the Metabolic Effects of LCZ696 and Amlodipine in Obese Hypertensive SubjectsCompletedNCT01631864Phase 2Results posted
- Study of the Efficacy and Safety of Aliskiren HCTZ vs Ramipril in Obese Patients (BMI ≥ 30) With Stage 2 HypertensionCompletedNCT00772577Phase 4Results posted
- Safety/Efficacy of Valsartan/Hydrochlorothiazide Combination Compared to Hydrochlorothiazide in Obese Hypertensive AdultsCompletedNCT00439738Phase 4Results posted
- Safety Study of LLF580 in Obese VolunteersCompletedNCT03466203Phase 1
- A Study of Octreotide Depot vs Saline Control in Pediatric Hypothalamic Obesity PatientsCompletedNCT00171613Phase 4
- Sandostatin LAR® Depot in Patients With Primary Insulin Hypersecretion (PIH) and at Least Moderate ObesityCompletedNCT00094146Phase 2
- Pediatric Hypothalamic ObesityCompletedNCT00076362Phase 4